Sharsheret
@Sharsheret
Followers
4K
Following
1K
Media
1K
Statuses
6K
We are the #Jewish #breastcancer and #ovariancancer organization: providing tailored support for you and your family, when and how you want it.
Nationwide
Joined March 2009
Congratulations to @genentech on this report
#Breaking: This #ESMOBreast25, we are excited to present ten-year follow-up data reinforcing the potential benefit of our treatment for HER2-positive early-stage breast cancer. Learn more: https://t.co/PM85MFAuNF
0
0
0
Congrats to our partners @GileadSciences and @Merck on Trodelvy® Plus Keytruda® that Demonstrates a Statistically Significant and Clinically Meaningful Improvement in Progression Free Survival in Patients With Previously Untreated PD-L1 Metastatic TNBC
gilead.com
Trodelvy Plus Keytruda Demonstrates a Statistically Significant and Clinically Meaningful Improvement in Progression Free Survival in Patients With Previously Untreated PD L1 Metastatic Triple...
0
0
0
#SharsheretPinkDay is only one week away! A community of thousands will join together to raise awareness about breast cancer and ovarian cancer, and help save lives through education. Sharsheret Pink Day is proudly sponsored in part by Merck.
0
1
1
Congratulations to Sharsheret partner @DaiichiSankyo for FDA approval of datopotamab deruxtecan-dlnk for unresectable or metastatic, HR-positive, HER2-negative breast cancer.
0
0
0
Our partner, @AstraZenecaUS announced that ENHERTU® (fam-trastuzumab deruxtecan-nxki) has been approved by the US FDA for the treatment of adult patients with unresectable or metastatic HER2-positive solid tumors who have received prior systemic treatment.
0
0
1
Genetic testing affects your children. Learn how Kerith spoke to her children about her positive BRCA test. Watch Kerith’s story: https://t.co/bKtKR4522B
@AstraZenecaUS
0
0
1
The @CDCgov’s Div of Cancer Prevention & Control launched the My Family Health Portrait: Cancer app, that helps individuals collect their family’s history of cancer & learn their risk for breast, ovarian & colorectal cancers. The app is available on Google Play & the App Store.
0
1
0
Our partner @SeagenGlobal announces: Seagen Phase 3 Trial of TUKYSA® (tucatinib) in Combination with Antibody-Drug Conjugate ado-trastuzumab emtansine Meets Primary Endpoint of Progression-Free Survival in Patients with Previously Treated HER2-Positive Metastatic Breast Cancer
0
0
0
News from Sharsheret's partner @AstraZeneca: Capivasertib in combination with FASLODEX® (fulvestrant) granted Priority Review in the US for patients with advanced HR-positive breast cancer. https://t.co/AEuLwsnMku
astrazeneca-us.com
0
0
0
Congrats to Sharsheret's partner, @GEHealthCare: the NCCN Guidelines now recommend F-18 fluoroestradiol (Cerianna) for ER+ positive mBC systemic staging workup. Read more: https://t.co/N70yB9xI4V
#Sharsheret #GEHealthCare #NCCN #F18fluoroestradiol #Cerianna
gehealthcare.com
GE HealthCare Announces FES PET Imaging Recommendation in NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) NCCN Guidelines®
1
0
1
Congrats to our partner @pfizer: the U.S. FDA expanded the indication for IBRANCE® (palbociclib) to include its use in combination with an AI as initial endocrine-based therapy for the treatment of HR+/HER2- mBC, regardless of menopausal status.
0
0
0
Sharsheret's Young Professionals Circle Casino Night is back on 12/17 🃏 🎲 Join us for a fun and meaningful evening of casino games, raffle prizes, food and drinks. Hurry! Prices go up on December 1st. 🎰 Register here: https://t.co/9ffpmJayNw
0
0
0
Click to watch as women w/ advanced cancer share inspirational stories, memories, feelings & advice https://t.co/mQFAPJv77O. This video series is part of the Living Legacies project made possible w/ generous support from @GileadSciences & in partnership with Memories Live.
0
1
2
Genetic results impact your treatment plan. Learn how Marissa's positive BRCA1 test impacted her breast cancer diagnosis. Watch Marissa's story: https://t.co/LEwmh2p9dv The @sharsheretofficial BRCA Hereditary Cancer video series is made possible w/ support from @Astrazeneca.
0
1
2
In honor of #BreastCancerAwarenessMonth @Sharsheret’s CEO Elana Silber joined @FLOTUS for the launch of a series of roundtables with @AmericanCancer. @Sharsheret is doing such important work to support Jewish women living with breast and ovarian cancer.
1
5
28
This #BreastCancerAwarenessMonth, we’re honored to support the work of our grantee, @Sharsheret, one of the nation’s leading Jewish cancer organizations.
1
3
8
Sharsheret goes to the @WhiteHouse! Sharsheret's CEO Elana Silber meets with leaders in the cancer community to launch Cancer Moonshot's National Roundtables on Breast and Cervical Cancer. Follow along as we share snippets from this groundbreaking day.
0
1
6
In this month’s blog, @GDbinky, Global Head of Advocacy & Strategic Relations, shares how advocacy groups are meeting the needs of the diverse #BreastCancer community: https://t.co/CqxarJIXKC
@SHAREing @tigerlilycares @SusanGKomen @Sharsheret @LivingBeyondBC
0
6
17
Need tips for managing your work life and cancer diagnosis? Join us at @CancerandCareers virtual West Coast Conference on Work & Cancer https://t.co/oiVQmATkCc
#CACWestCoast
0
3
4